<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: MuGard</title>
	<atom:link href="http://www.accesspharma.com/newsroom/mugard/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.accesspharma.com/newsroom</link>
	<description>Breaking News, stock info, SEC filings, multimedia and other information on Access Pharmaceuticals, Inc.</description>
	<lastBuildDate>Thu, 24 Jun 2010 13:01:37 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Access Pharmaceuticals provides update on MuGard commercial launch and first European clinicians feedback &#124; Access Pharmaceuticals, Inc. Newsroom</title>
		<link>http://www.accesspharma.com/newsroom/mugard/comment-page-1/#comment-232</link>
		<dc:creator>Access Pharmaceuticals provides update on MuGard commercial launch and first European clinicians feedback &#124; Access Pharmaceuticals, Inc. Newsroom</dc:creator>
		<pubDate>Thu, 15 Oct 2009 12:04:10 +0000</pubDate>
		<guid isPermaLink="false">http://newsroom.accesspharma.com/?page_id=325#comment-232</guid>
		<description>[...] Corporate Fact Sheet Scientific Publications ProLindac™ Fact Sheet MuGard™ Fact Sheet Cobalamin™ Fact Sheet Angiolix® Fact Sheet Prodrax® Fact Sheet Alchemix® Fact Sheet [...]</description>
		<content:encoded><![CDATA[<p>[...] Corporate Fact Sheet Scientific Publications ProLindac™ Fact Sheet MuGard™ Fact Sheet Cobalamin™ Fact Sheet Angiolix® Fact Sheet Prodrax® Fact Sheet Alchemix® Fact Sheet [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
